Cargando…

Matrix Effectors and Cancer

Detalles Bibliográficos
Autores principales:	Piperigkou, Zoi, Karamanos, Nikos K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750795/ https://www.ncbi.nlm.nih.gov/pubmed/35008364 http://dx.doi.org/10.3390/cancers14010200

Ejemplares similares

Trends in extracellular matrix biology
por: Kyriakopoulou, Konstantina, et al.
Publicado: (2022)

Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer
por: Piperigkou, Zoi, et al.
Publicado: (2021)

miR-200b restrains EMT and aggressiveness and regulates matrix composition depending on ER status and signaling in mammary cancer
por: Piperigkou, Zoi, et al.
Publicado: (2020)

Epigenetic Alterations in Triple-Negative Breast Cancer—The Critical Role of Extracellular Matrix
por: Zolota, Vasiliki, et al.
Publicado: (2021)

Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer
por: Papakonstantinou, Efthymia, et al.
Publicado: (2022)

ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer
por: Kyriakopoulou, Konstantina, et al.
Publicado: (2020)

Extracellular Matrix-Mediated Breast Cancer Cells Morphological Alterations, Invasiveness, and Microvesicles/Exosomes Release
por: Franchi, Marco, et al.
Publicado: (2020)

Long filopodia and tunneling nanotubes define new phenotypes of breast cancer cells in 3D cultures
por: Franchi, Marco, et al.
Publicado: (2020)

Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells
por: Tavianatou, Anastasia-Gerasimoula, et al.
Publicado: (2019)

The Role of Exosomes in Epithelial–to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer
por: Mastronikolis, Nicholas S., et al.
Publicado: (2023)

ESR2 Drives Mesenchymal-to-Epithelial Transition in Triple-Negative Breast Cancer and Tumorigenesis In Vivo
por: Piperigkou, Zoi, et al.
Publicado: (2022)

Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition
por: Karamanou, Konstantina, et al.
Publicado: (2017)

Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status
por: Koutsakis, Christos, et al.
Publicado: (2021)

Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer Cells
por: Franchi, Marco, et al.
Publicado: (2019)

Enhancement of mesenchymal stem cells’ chondrogenic potential by type II collagen-based bioscaffolds
por: Piperigkou, Zoi, et al.
Publicado: (2023)

Development of Environmentally Friendly Biocidal Coatings Based on Water-soluble Copolymers for Air-cleaning Filters
por: Druvari, Denisa, et al.
Publicado: (2022)

Editorial: Molecules of the extracellular matrix as cancer targets
por: Karamanos, Nikos K., et al.
Publicado: (2022)

New Analogs of Polyamine Toxins from Spiders and Wasps: Liquid Phase Fragment Synthesis and Evaluation of Antiproliferative Activity
por: Vassileiou, Christos, et al.
Publicado: (2022)

Complexity of matrix phenotypes
por: Iozzo, Renato V., et al.
Publicado: (2020)

Nephronectin as a Matrix Effector in Cancer
por: Magnussen, Synnøve Norvoll, et al.
Publicado: (2021)

Lymphocyte Differentiation and Effector Functions
por: Olsen Saraiva Camara, Niels, et al.
Publicado: (2012)

Androgens in rheumatoid arthritis: when are they effectors?
por: Cutolo, Maurizio
Publicado: (2009)

Mesenchymal niche: the sensor and effector of leukemogenesis
por: Oh, Il-Hoan
Publicado: (2015)

Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas
por: Kavasi, Rafaela-Maria, et al.
Publicado: (2022)

The effectors of innate immunity: DAMPs, DAMEs, or DIMEs?
por: Pisetsky, David S
Publicado: (2013)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

The formation of pre-effectors in the steady state opens a new perspective for cancer immunosurveillance
por: Surnov, Alexey, et al.
Publicado: (2021)

T-cells in myocardial infarction: Culprit instigators or mere effectors?
por: Liberale, Luca, et al.
Publicado: (2018)

Extracellular Matrix and Cancer: An Intricate Affair
por: Mongiat, Maurizio
Publicado: (2023)

Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
por: Zhang, Wen, et al.
Publicado: (2018)

Inflammation and breast cancer. Metalloproteinases as common effectors of inflammation and extracellular matrix breakdown in breast cancer
por: Hojilla, Carlo V, et al.
Publicado: (2008)

T3SS effectors in Vibrios: Homology in sequence, diversity in biological functions?
por: Osorio, Carlos R.
Publicado: (2018)

Colorectal Cancer Cell Invasion and Functional Properties Depend on Peri-Tumoral Extracellular Matrix
por: Franchi, Marco, et al.
Publicado: (2023)

Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector
por: Tomita, Tadakimi, et al.
Publicado: (2021)

Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Understanding the extracellular matrix
por: Shin, Kwanwoo
Publicado: (2013)

Mixed Matrix Membranes
por: Casado-Coterillo, Clara
Publicado: (2019)

Effector Tregs: middle-men in TGFβ activation
por: Worthington, John J., et al.
Publicado: (2015)

Notch controls effector CD8(+) T cell differentiation
por: Duval, Frédéric, et al.
Publicado: (2015)

Extracellular matrix components modulate different stages in β(2)-microglobulin amyloid formation
por: Benseny-Cases, Núria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8skiqeg1b3trr6jmdlo6joasta